Abstract:Purpose Sirtuin7 (SIRT7), as a member of the sirtuin and NAD + -dependent protein-modifying enzyme family, plays an important role in regulating cellular metabolism, stress responses, tumorigenesis, and aging. Ubiquitination and deubiquitination are reversible post-translational modifications that regulate protein stability, enzyme activity, protein–protein interactions, and cellular signaling transduction. However, whether SIRT7 is regulated by deubiquitination signaling is unclear. This study aims to elucidate the molecular mechanism of SIRT7 via deubiquitination signaling. Methods USP17L2 or SIRT7-targeting shRNAs were used to deplete USP17L2 or SIRT7. Western blot was applied to assess the effects of USP17L2 or SIRT7 depletion. A co-immunoprecipitation assay was used to detect the interaction relationship. Cell Counting Kit-8 assays were applied to assess the viability of breast cancer cells. An immunohistochemistry assay was employed to detect the protein level in samples from breast cancer patients, and the TCGA database was applied to analyze the survival rate of breast cancer patients. Statistical analyses were performed with the Student’s t test (two-tailed unpaired) and χ 2 test. Results We find that the deubiquitinase USP17L2 interacts with and deubiquitinates SIRT7, thereby increasing SIRT7 protein stability. In addition, USP17L2 regulates DNA damage repair through SIRT7. Furthermore, SIRT7 polyubiquitination is increased by knocking down of USP17L2, which leads to cancer cells sensitizing to chemotherapy. In breast cancer patient samples, high expression of USP17L2 is correlated with increased levels of SIRT7 protein. In conclusion, our study demonstrates that the USP17L2-SIRT7 axis is the new regulator in DNA damage response and chemo-response, suggesting that USP17L2 may be a prognostic factor and a potential therapeutic target in breast cancer. Conclusion Our results highlighted that USP17L2 regulates the chemoresistance of breast cancer cells in a SIRT7-dependent manner. Moreover, the role of USP17L2 as a potential therapeutic target in breast cancer and a prognostic factor for patients was elucidated.

USP4 is regulated by Akt phosphorylation and deubiquitylates TGF-beta type I receptor

USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-[beta] type I receptor

USP4 is Regulated by AKT Phosphorylation and Directly Deubiquitylates TGF-β Type I Receptor

USP4 Promotes Invasion of Breast Cancer Cells Via Relaxin/TGF-β1/Smad2/MMP-9 Signal.

USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling.

Ubiquitin-Specific Protease 4 (Usp4) Targets Traf2 And Traf6 For Deubiquitination And Inhibits Tnf Alpha-Induced Cancer Cell Migration

USP1-WDR48 deubiquitinase complex enhances TGF-β induced epithelial–mesenchymal transition of TNBC cells via stabilizing TAK1

The Deubiquitinating Enzyme USP4 Regulates BRCA1 Stability and Function

Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 is Required for Potentiating Colorectal Oncogenesis.

Usp4 Inhibits Smad4 Monoubiquitination and Promotes Activin and Bmp Signaling

Usp1-Wdr48 Deubiquitinase Complex Enhances Tgf-Beta Induced Epithelial-Mesenchymal Transition Of Tnbc Cells Via Stabilizing Tak1

USP8 promotes cancer progression and extracellular vesicle‐mediated CD8+ T cell exhaustion by deubiquitinating the TGF‐β receptor TβRII

USP2a Supports Metastasis by Tuning TGF-β Signaling.

Original Protein tyrosine phosphatase PTPN2 regulates TGF- signaling through Smad4 dephosphorylation

Deubiquitinating enzymes USP4 and USP17 finetune the trafficking of PDGFRβ and affect PDGF-BB-induced STAT3 signalling

USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells

USP4 targets TAK1 to downregulate TNF|[alpha]|-induced NF-|[kappa]|B activation

Usp4 Inhibits P53 Through Deubiquitinating and Stabilizing Arf-Bp1

Phosphorylation and Activation of Ubiquitin-Specific Protease-14 by Akt Regulates the Ubiquitin-Proteasome System.

Supplemental Fig 5 from Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x–SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis

Ubiquitin-specific Protease 4 Promotes Hepatocellular Carcinoma Progression Via Cyclophilin A Stabilization and Deubiquitination.